Adaptimmune Therapeutics

0.33
0.03 (8.20%)
At close: Apr 03, 2025, 3:59 PM
0.32
-1.28%
Pre-market: Apr 04, 2025, 08:28 AM EDT

Adaptimmune Therapeutics Revenue

Adaptimmune Therapeutics reported an annual revenue of $178.03M, reflecting a 195.34% growth. For the quarter ending December 31, 2024, Adaptimmune Therapeutics generated $3.22M in revenue.
Revenue (ttm)
$178.03M
Revenue Growth
195.34%
Price / Sales Ratio
0.76
Revenue / Employee
$351.84K
Employees
506
Market Cap
84.21M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 178.03M +195.34%
Dec 31, 2023 60.28M +122.05%
Dec 31, 2022 27.15M +341.50%
Dec 31, 2021 6.15M +55.36%
Dec 31, 2020 3.96M n/a